Skip to main content
. 2022 May 20;13(5):12309–12325. doi: 10.1080/21655979.2022.2072619

Table 1.

Expression of miR-744-5p and TGFB1 according to patients’ clinical characteristics

 
 
miR-744-5p expression
 
TGFB1 expression
 
characteristics total Tumor tissue para-carcinoma tissue P value Tumor tissue para-carcinoma tissue P value
Age (y)       0.291     0.377
< 18 14 0.93 ± 0.38 1.34 ± 0.40 0.024* 2.15 ± 0.86 1.24 ± 0.61 0.001***
≥ 18 11 0.91 ± 0.26 1.46 ± 0.47 0.017* 2.42 ± 0.65 1.42 ± 0.74 0.003**
Gender       0.391     0.374
Female 13 0.98 ± 0.37 1.30 ± 0.41 0.103 2.14 ± 0.77 1.40 ± 0.68 0.002**
Male 12 0.86 ± 0.27 1.56 ± 0.41 0.002** 2.41 ± 0.79 1.23 ± 0.66 0.001***
Location       0.572     0.531
Arm/hand 11 0.96 ± 0.32 1.72 ± 1.05 0.029* 2.38 ± 0.77 1.35 ± 0.66 0.004**
Leg/foot 14 0.89 ± 0.34 1.41 ± 0.44 0.015* 2.18 ± 0.80 1.30 ± 0.69 0.001***
TNM stage       0.135     0.014*
I 6 1.04 ± 0.25 1.26 ± 0.38 0.401 1.80 ± 0.60 1.21 ± 0.50 0.054
II 11 1.03 ± 0.30 1.40 ± 0.41 0.075 2.09 ± 0.67 1.27 ± 0.74 0.004**
III/IV 8 0.67 ± 0.29 1.59 ± 0.47 0.005** 2.88 ± 0.71 1.46 ± 0.72 0.003**
Tumor size       0.017*     0.014*
< 5 cm 11 1.09 ± 0.29 1.31 ± 0.41 0.272 1.86 ± 0.46 1.25 ± 0.53 0.001***
≥ 5 cm 14 0.89 ± 0.24 1.43 ± 0.43 0.006* 2.44 ± 0.84 1.37 ± 0.84 0.004**
Lung metastasis       0.005**     0.005**
Yes 8 0.67 ± 0.29 1.59 ± 0.47 0.005** 2.88 ± 0.71 1.46 ± 0.72 0.003**
No 17 1.04 ± 0.27 1.35 ± 0.39 0.043* 1.99 ± 0.64 1.25 ± 0.65 0.000***